Tag: NQ

Blue Horseshoe Stocks: NQ Review & More

NQ Mobile, Inc.  NQ

Our coverage of NQ stretches all the way back to the Fall of 2013 when the stock made a huge run, and we tracked it to a similar albeit smaller-scale spike in October, so we are quite familiar with this play. We have good reason to re-assess NQ this morning in the wake of an interesting PR, coupled with a good positioning of the chart.

In terms of the NQ chart, there a couple of finer points that we’ll point out on the following snapshot:

This morning’s PR relates to a big open market stock repurchase by management which seems to be fueling NQ in the premarket. >>> VIEW PR  


Cannabis Coverage:

A few of the marijuana-related stocks we were mentioning yesterday morning managed to put up some solid numbers over the course of the day.

CBIS traded in a range from .068-.08 (+17%) on roughly 4X its monthly average volume.

MCIG did slightly better as recorded a 19% move from .15 to .178, trading more than twice its average volume.

EAPH also had a heavy volume day to the tune of roughly 3X its average, and made a healthy jump of 21% as it traded from its open at .024 to a high of .029.

As medical and recreational marijuana acceptance continues to spread, we’ll need to keep a close eye on these and many other cannabis plays, as we tend to believe that growth in this arena will be more substantial in 2015 than any previous year.

A few other pot plays to watch this week: WDHR, NRTI, MDCN, LATF, VPOR

Extended Watchlist:
CYTR, NERV, FRO, CPST, DARA, MNK, SNSS, RNN

Blue Horseshoe Stocks: NQ, RAD Reviews & More

NQ Mobile, Inc. NQ

NQ appeared at the top of our extended watchlist yesterday and stood out as the day’s top pick. The stock increased gradually all day long from an early low of 3.86, and touched 4.77 just prior to the closing bell. That solid intraday move was good for gains of up to 24% as NQ traded close to 6X its 3-month average volume.

The spike came on the heels of a big announcement from the company as it gears up for an $80M buyback program that will last for the duration of 2015.

BEIJING and DALLAS, Dec. 23, 2014 /PRNewswire/ – NQ Mobile, Inc. (“NQ Mobile” or the “Company“) (NQ), a leading global provider of mobile internet services, announced today that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to US$80 million of its shares over the next 12 months. >> FULL PR

Rite-Aid Corp. RAD

Just a reminder for those who might have missed our close coverage of RAD over the past week, we latched onto this stock last Tuesday, catching it at a low of 5.79. We’ve seen incremental gains from this play from that time, and yesterday it continued to press upward, setting a new high at 7.45. That marked an overall increase of 29% that we’ve observed in just one week.

The stock continues to push its way up in premarket trading this morning, having traded as high as 7.54 so far, so we’ll be certain to pay close attention as we close out the early portion of this split trading week, and once we return on Friday.

As we stated yesterday, according to the opinions of many analysts, RAD has room to see a PPS in the $8-range, and with the movements we’ve tracked over a short period of time we wouldn’t be at all surprised to see that happen.

The markets wrap up at 1PM this afternoon for the start of the holiday break. We want to take this opportunity to extend our warmest Season’s Greetings to all of our readers regardless of how you will be spending the hiatus. Be safe and well, and we will be back bright and early on Friday to close out the week! Cheers!

Extended Watchlist:
ISNS, DRD, HALO, WATT, LIQD(Gap-Down, Watching for Bottom)

Blue Horseshoe Stocks: RAD, ACHN Recaps & More

Achillon Pharmaceuticals, Inc. ACHN

ACHN stood out amongst the stocks we discussed in yesterday’s morning report. The move came in conjunction with the announcement that the company’s Hep C treatment currently in trials had successfully cured all of the patients in the latest clinical test.

As a result ACHN ran from a morning low of 14.56 on up to 16.87 for a solid 16% intraday move, on its highest volume traded since June.

We’ve been tracking ACHN for over a month now, and in that time have observed a low of 12.00 (Nov. 12th). As of yesterday’s high, that represents an overall increase of 40% in a relatively short amount of time.

Rite-Aid Corp. RAD

We began paying attention to RAD on Tuesday of last week, and the stock has made some good progress since then. Yesterday was no exception, with RAD adding another 6% to the healthy upward movements we’ve already witnessed.

From the low of 5.79 we observed last Tuesday after adding it to our watchlist for the first time, to yesterday’s high of 7.19, equates to a move of 25% in a span of just five sessions. That’s more than enough to hold our attention as we head into the New Year.

It’s worth mentioning that the Cowen Group investment research arm upgraded RAD from a ‘Neutral’ to an ‘Outperform’ rating, with a price target of 8.50/share, and one of our favorite sites, BARCHART.com is currently rating RAD a 100% Short-Term ‘Buy’, with an 88% ‘Buy’ Rating overall.

Extended Watchlist:
NQ, ARIA, ALSK, CYTK, ICLD, DRYS

Blue Horseshoe Stocks: APP, CERS Recaps & More

American Apparel Inc. APP

It appears as if we brought APP back into the discussion yesterday at an opportune time, as the stock enjoyed a healthy intraday move on more than twice the 3-month average trading volume.

After briefly seeing a low of .63 the stock gradually built its way up to an afternoon high of .69, an increase of roughly 10%, and in the premarket this morning APP has already traded as high as .78. That pushes the overnight increase on APP to 24%

Yesterday we mentioned that breaking of the 200DMA of .74 was a key event that needed to take place and we’ve seen that happen this morning, so APP is certainly going to remain high on our watchlists as we head into week’s end.

Cerus Corp. CERS

CERS was included in yesterday’s extended watchlist, and made a solid move during the day’s session. From a low of 5.26 the stock made a run at a high of 5.94, a modest yet notable 13% increase.

It came on the heels of the announcement that the company had received the green light from the FDA on its product that limits the risk of infection-transmission in blood transfusions. We always like a good FDA-approval play so we will definitely be monitoring this play in coming sessions.

CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (CERS) today announced that the U.S. Food and Drug Administration (FDA) has approved the INTERCEPT Blood System for plasma. The INTERCEPT plasma system is approved for ex vivo preparation of plasma in order to reduce the risk of transfusion-transmitted infection (TTI) when treating patients requiring therapeutic plasma transfusion. >> FULL PR

Eco Science Solutions, Inc. ESSI

We’ve still got ESSI on our radars, and wanted to remind our readers of this even as the stock has been trading in a tight channel between .20-.25 since we last took a look at it. The reason we still find ESSI attractive is that it boasts a tight share structure, and while we haven’t seen much in the way of volume, should that change, even the slightest amount of buying pressure could send ESSI flying.

From a business perspective, we’re also interested in the technology the company is working on, its innovative re-imagining on classic spark plug design. So despite not seeing much short-term activity, ESSI still has many of the hallmarks of a high-potential play that we’ll want to watch closely into the New Year.

We’ve drawn up a video on the current standing of the ESSI Chart, so take a look at that by clicking the graphic below:

If you missed our initial report on ESSI and its spark plug technology, go ahead and take a look now: ESSI Report

Extended Watchlist:
RAD, JNUG, EXXI, FRO, RGSE, AGEN, NQ, THCZ

Blue Horseshoe Stocks: NVAX, NQ & More

Novavax, Inc. NVAX 

NVAX is the latest Ebola-related stock to catch our eye, and while the initial fear that was driving a lot of these plays has calmed as people realize that the virus doesn’t exactly spread like wildfire, there is much being made of efforts to find a working vaccine and NVAX is attempting to answer that call.

The company announced today that it had presented at the 8th Vaccine and ISV Conference in Philadelphia on Sunday on what was called the first Ebola Vaccine Candidate based on the 2014 Guinea strain that caused the current outbreak in West Africa.

The company said it expects to begin Phase I testing by December, so we’re going to add NVAX to our watchlists for the time being. Additionally, the stock is gapping up to the tune of 10% here in the premarket, and the chart appears to have the possibility of a Golden Cross in the making.

NQ Mobile, Inc. NQ

This is a play we’ve tracked continuously since late this spring. After witnessing a nice move back in July from the low $4-range to the mid-$7’s, the stock had been under general consolidation until it found and bounced off of support about 6 weeks ago. It has made a nice steady recovery from that point on, and is gaining more traction this morning as it gaps up in the premarket on the heels of a PR.

The mobile security has just company submitted the necessary back-filings to once again become fully compliant, and no anomalies or adverse findings were uncovered, which adds another dimension to this play.

We also like the space NQ operates in- with mobile devices permeating every aspect of the current culture, the need for mobile security services such as those provided by NQ only stands to grow in the future.

Side Note:
PTIE, DRRX (Two that are gapping down significantly; we will want to watch for an eventual bounce)

Extended Watchlist:
ISR, AEZS, TSEM, CEMI,

Get Our FREE Daily Reports!

SUBSCRIBE